Literature DB >> 22744873

Craniopharyngioma: history.

Garni Barkhoudarian1, Edward R Laws.   

Abstract

One of the most challenging parasellar tumors, the craniopharyngioma was first described by Friedrich Albert von Zenker in 1857. Following improved understanding of pituitary gland physiology and development, Jakob Erdheim became the first to accurately describe the histopathological characteristics of a craniopharyngioma. Babinski's described the clinical presentation of these patients, with "sexual infantilism and dystrophic adiposity." The first successful surgical resection of a craniopharyngioma was performed by A. E. Halstead of Chicago of July 21st, 1909. Harvey Cushing embraced the transsphenoidal approach for the majority of his pituitary operations, but favored the transcranial approach for craniopharyngiomas. The introduction of antibiotics, corticosteroids, and microscopy significantly improved surgical outcomes. As technology improved, trans-cranial and transsphenoidal approaches were implemented depending on tumor characteristics. Adjuvant therapy, such as stereotactic radiosurgery, radioisotope brachytherapy, and intracapsular chemotherapy have improved overall tumor control rates and decreased the incidence of complications. Building on over 100 years of surgery for "the most formidable of intracranial tumors," results continue to improve. Regardless, challenges continue to remain requiring surgical insight and innovation.

Entities:  

Mesh:

Year:  2013        PMID: 22744873     DOI: 10.1007/s11102-012-0402-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  49 in total

1.  Cortisone as an aid in the surgical treatment of craniopharyngiomas.

Authors:  J S TYTUS; H S SELTZER; E A KAHN
Journal:  J Neurosurg       Date:  1955-11       Impact factor: 5.115

2.  Treatment of craniopharyngiomas--the stereotactic approach in a ten to twenty-three years' perspective. I. Surgical, radiological and ophthalmological aspects.

Authors:  E O Backlund; B Axelsson; C G Bergstrand; A L Eriksson; G Norén; E Ribbesjö; T Rähn; P O Schnell; L Tallstedt; M Sääf
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  The surgery of the craniopharyngiomas.

Authors:  P D GORDY; M M PEET; E A KAHN
Journal:  J Neurosurg       Date:  1949-11       Impact factor: 5.115

4.  Craniopharyngiomas in children and adults.

Authors:  J T Hoff; R H Patterson
Journal:  J Neurosurg       Date:  1972-03       Impact factor: 5.115

5.  Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma.

Authors:  S Cavalheiro; P A Dastoli; N S Silva; S Toledo; H Lederman; M C da Silva
Journal:  Childs Nerv Syst       Date:  2005-06-14       Impact factor: 1.475

6.  Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients.

Authors:  M G Yaşargil; M Curcic; M Kis; G Siegenthaler; P J Teddy; P Roth
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

7.  Endocrine function, morbidity, and mortality after surgery for craniopharyngioma.

Authors:  K R Lyen; D B Grant
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

8.  Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series.

Authors:  Paul A Gardner; Amin B Kassam; Carl H Snyderman; Ricardo L Carrau; Arlan H Mintz; Steven Grahovac; Susan Stefko
Journal:  J Neurosurg       Date:  2008-07       Impact factor: 5.115

9.  Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients.

Authors:  M J Thomsett; F A Conte; S L Kaplan; M M Grumbach
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

10.  Transpetrosal-transtentorial approach and its application in the therapy of retrochiasmatic craniopharyngiomas.

Authors:  A Hakuba; S Nishimura; Y Inoue
Journal:  Surg Neurol       Date:  1985-10
View more
  12 in total

1.  Combined endoscopic approach in the management of suprasellar craniopharyngioma.

Authors:  Chandrashekhar E Deopujari; Vikram S Karmarkar; Nishit Shah; Ravindran Vashu; Rahul Patil; Chandan Mohanty; Salman Shaikh
Journal:  Childs Nerv Syst       Date:  2018-02-12       Impact factor: 1.475

Review 2.  ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.

Authors:  Priscilla K Brastianos; Sandro Santagata
Journal:  Eur J Endocrinol       Date:  2015-11-12       Impact factor: 6.664

3.  CRANIOPHARYNGIOMA - CLINICAL AND THERAPEUTIC OUTCOME DATA IN A MIXED COHORT OF ADULT AND PAEDIATRIC CASES.

Authors:  C Capatina; M Vintila; I Gherlan; A Dumitraşcu; A Caragheorgheopol; C Procopiuc; V Ciubotaru; C Poiana
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

4.  Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.

Authors:  Priscilla K Brastianos; Amaro Taylor-Weiner; Peter E Manley; Robert T Jones; Dora Dias-Santagata; Aaron R Thorner; Michael S Lawrence; Fausto J Rodriguez; Lindsay A Bernardo; Laura Schubert; Ashwini Sunkavalli; Nick Shillingford; Monica L Calicchio; Hart G W Lidov; Hala Taha; Maria Martinez-Lage; Mariarita Santi; Phillip B Storm; John Y K Lee; James N Palmer; Nithin D Adappa; R Michael Scott; Ian F Dunn; Edward R Laws; Chip Stewart; Keith L Ligon; Mai P Hoang; Paul Van Hummelen; William C Hahn; David N Louis; Adam C Resnick; Mark W Kieran; Gad Getz; Sandro Santagata
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 38.330

5.  Craniopharyngioma: Survivin expression and ultrastructure.

Authors:  Jiang Zhu; Chao You
Journal:  Oncol Lett       Date:  2014-11-07       Impact factor: 2.967

6.  Learning from cases: Analysis of two cases of craniopharyngioma from the 19 th to the 21 st centuries.

Authors:  John R Apps; J Ciaran Hutchinson; Susan Shelmerdine; Alex Virasami; Eduard Winter; Thomas S Jacques; Juan-Pedro Martinez-Barbera; Owen Arthurs; Thomas Czech
Journal:  F1000Res       Date:  2019-08-30

7.  MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and in vitro experiments.

Authors:  Minde Li; Lin Zhou; Shaoyang Li; Linchun Fang; Le Yang; Xiao Wu; Chenxing Yang; Youyuan Bao; Sihai Lan; Zhigao Tong; Suyue Zheng; Bin Tang; Erming Zeng; Shenhao Xie; Cheng Chen; Tao Hong
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 2.967

8.  Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing.

Authors:  Juan He; Zhen Zeng; Yuelong Wang; Jiaojiao Deng; Xin Tang; Fujun Liu; Jianhan Huang; Hongxu Chen; Ruichao Liang; Xin Zan; Zhiyong Liu; Aiping Tong; Gang Guo; Jianguo Xu; Xiaofeng Zhu; Liangxue Zhou; Yong Peng
Journal:  Mol Cancer       Date:  2021-12-18       Impact factor: 27.401

9.  Haemorrhagic presentation of a craniopharyngioma in a pregnant woman.

Authors:  Cesare Zoia; Andrea Cattalani; Elena Turpini; Viola Marta Custodi; Marco Benazzo; Fabio Pagella; Paolo Carena; Elisabetta Lovati; Pietro Lucotti; Paolo Gaetani
Journal:  Case Rep Neurol Med       Date:  2014-08-05

10.  Hypothalamic injury patterns after resection of craniopharyngiomas and correlation to tumor origin: A study based on endoscopic observation.

Authors:  Le Yang; ShenHao Xie; Bin Tang; Xiao Wu; ZhiGao Tong; Chao Fang; Han Ding; YouYuan Bao; SuYue Zheng; Tao Hong
Journal:  Cancer Med       Date:  2020-11-03       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.